studyfinds5m
Scientists develop potent weapon against Alzheimer’s protein clumps
Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.
ScienceAlert on MSN2d
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic Tangles
The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
BioWorld5d
RI-AG03 targets main promoters of tau protein aggregation at once
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
the Westmorland Gazette8h
Alzheimer's treatment breakthrough for Kendal-born doctor
Dr Anthony Aggidis, a former Postdoctoral Research Associate at Lancaster University, led the study of the drug RI-AG03.
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Neuroscience News5d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Science Daily5d
Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
EuropaWire5d
Breakthrough Peptide Inhibitor Targets Tau Protein Aggregation, Paving the Way for New Alzheimer’s Treatments
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
McKnight's Long-Term Care News2d
Promising new Alzheimer’s drug candidate developed by international research team
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
New York Post6d
‘One-of-a-kind’ new Alzheimer’s drug shows promise: ‘An exciting development’
Now, an international team led by Lancaster University in the UK says it has developed a drug called RI-AG03 that targets and blocks the two “hot spots” where tau clumping tends to occur.